We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Craneware Plc | LSE:CRW | London | Ordinary Share | GB00B2425G68 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -50.00 | -2.23% | 2,190.00 | 2,150.00 | 2,230.00 | 2,190.00 | 2,190.00 | 2,190.00 | 1,300 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Prepackaged Software | 174.02M | 9.23M | 0.2626 | 85.30 | 787.53M |
From Apr 2019 to Apr 2024
TIDMCRW
RNS Number : 9153F
Craneware plc
17 November 2015
Craneware plc
("Craneware" or the "Company")
AGM Statement
17 November 2015 - Craneware plc (AIM: CRW.L), the leader in Value Cycle solutions for the US healthcare market, will be holding its Annual General Meeting today at 9am. At the meeting, Keith Neilson, CEO of the Company, will make the following statement:
"We have experienced a positive start to trading in the first few months of the year. In June, we launched the Value Cycle, our vision for the process and culture by which healthcare providers pursue quality patient outcomes and optimal financial performance within a healthcare market moving towards value-based care. Our leadership in this area has further strengthened Craneware's position as a trusted partner for US healthcare organisations as they look to solve the challenges of the new value based reimbursement models.
This positive impact of the Value Cycle on the level of sales activity combined with the contribution of the prior year's sales flowing through to the current year financial results and the continued high levels of cash generation, mean we are well positioned to continue to execute on our growth strategy."
Craneware will be hosting an analyst and investor presentation at 11am today. The presentation to be given at the meeting will cover topics including the evolution of the US healthcare market towards value-based care, the escalation of patient engagement and consumerism, and the Value Cycle. The presentation will contain no new material information.
Copies of the presentation will be made available on the Company's website at www.craneware.com.
For further information, please contact:
Craneware plc Peel Hunt Alma +44 (0)131 +44 (0)20 7418 +44 (0)7515 805 550 3100 8900 218 Keith Neilson, Dan Webster Caroline Forde CEO Craig Preston, Richard Kauffer Hilary Buchanan CFO
About Craneware
Craneware is the leader in automated value cycle solutions that help US provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Boston, Nashville and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
AGMBCBDBUGBBGUL
(END) Dow Jones Newswires
November 17, 2015 02:00 ET (07:00 GMT)
1 Year Craneware Chart |
1 Month Craneware Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
